Registered in 2014 and still active, Healx Limited operates from third-floor offices on Charter House in central Cambridge. The company is classified under SIC 74909, which covers professional, scientific and technical activities not elsewhere specified. That broad category, combined with the name Healx and Cambridge's reputation as a life sciences hub, strongly suggests a business focused on healthcare innovation. Healx most likely applies artificial intelligence and computational methods to drug discovery, a field that has grown rapidly around Cambridge's research institutions. Its activities probably involve using machine learning to analyse biomedical data, identify therapeutic potential in existing drugs, and accelerate the development of treatments for rare conditions. The exact services are not itemised in public records, but the SIC code points to specialised technical work rather than manufacturing or retail. Healx holds a Skilled Worker sponsor licence with an A rating, confirming that it can legally hire workers from outside the UK. This indicates an active and ongoing need for skilled staff, likely researchers, data scientists, and other technical professionals. The company's size is not reported, but its registration as a private limited company and the specialised nature of its work suggest a small or medium-sized enterprise. International operations are not explicitly documented, though biotech companies of this kind often collaborate across borders and serve global clients. The combination of a Cambridge base, a health-tech name, and an active sponsor license gives a reasonable picture of a growing, research-driven company looking for specialised talent.

Registered in 2014 and still active, Healx Limited operates from third-floor offices on Charter House in central Cambridge. The company is classified under SIC 74909, which covers professional, scientific and technical activities not elsewhere specified. That broad category, combined with the name Healx and Cambridge's reputation as a life sciences hub, strongly suggests a business focused on healthcare innovation. Healx most likely applies artificial intelligence and computational methods to drug discovery, a field that has grown rapidly around Cambridge's research institutions. Its activities probably involve using machine learning to analyse biomedical data, identify therapeutic potential in existing drugs, and accelerate the development of treatments for rare conditions. The exact services are not itemised in public records, but the SIC code points to specialised technical work rather than manufacturing or retail. Healx holds a Skilled Worker sponsor licence with an A rating, confirming that it can legally hire workers from outside the UK. This indicates an active and ongoing need for skilled staff, likely researchers, data scientists, and other technical professionals. The company's size is not reported, but its registration as a private limited company and the specialised nature of its work suggest a small or medium-sized enterprise. International operations are not explicitly documented, though biotech companies of this kind often collaborate across borders and serve global clients. The combination of a Cambridge base, a health-tech name, and an active sponsor license gives a reasonable picture of a growing, research-driven company looking for specialised talent.